Article

Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Breast Cancer Research and Treatment (Impact Factor: 4.2). 05/2009; 120(2):357-67. DOI: 10.1007/s10549-009-0393-2
Source: PubMed

ABSTRACT To investigate a presumed crosstalk between estrogen receptor alpha (ERalpha) and the TGF-beta signaling pathway in breast cancer, we analyzed the TGF-beta-induced expression of the plasminogen activator inhibitor 1 (PAI-1) gene in ER-positive MCF-7 cells. After siRNA-mediated knock-down of endogenous ERalpha, the transcription level of PAI-1 was upregulated, pointing to an attenuation of TGF-beta signaling by the presence of ERalpha. We verified these findings by a vice versa approach using a primary ER-negative cell model transiently overexpressing either ERalpha or ERbeta. We found that ERalpha, but not ERbeta, led to a strong inhibition of the TGF-beta1 signal, monitored by TGF-beta reporter assays. This attenuation was completely independent of receptor stimulation by beta-estradiol (E2) or inhibition by the pure antagonist ICI 182.780 (ICI). Our results indicate a permanent repression of PAI-1 by ERalpha and suggest a ligand-independent crosstalk between ERalpha and TGF-beta signaling in breast cancer cells.

Download full-text

Full-text

Available from: Matthias B Stope, Jun 30, 2015
0 Followers
 · 
260 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Der pleiotrope Wachstumsfaktor „transforming growth factor β“ (TGF-β) ist in diverse Signalwege involviert und kann eine Vielzahl von Zellantworten beeinflussen. Bei Entstehung und Karzinogenese des Prostatakarzinoms (PCa) können dies sowohl antionkogene Mechanismen (Wachstumshemmung, Apoptose) als auch proonkogene Prozesse sein (Proliferation, Zellbeweglichkeit, Modulierung der Tumorumgebung). Die ursprünglich antiproliferative Wirkung von TGF-β wird dabei im Verlauf der Tumorprogression immer mehr von proonkogenen Effekten überlagert, die häufig durch die Interaktion mit proliferativen Signalkaskaden wie „Mitogen-activated protein-kinase-“ (MAP-Kinase-) oder Androgenrezeptor- (AR-)Signalwegen vermittelt werden. Obgleich TGF-β ein wichtiger Modulator der PCa-Progression ist, sind die zugrundeliegenden molekular-pathologischen Prozesse bisher nur unvollständig verstanden.
    Der Urologe 03/2012; 52(3). DOI:10.1007/s00120-012-3049-5 · 0.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adipose-derived stromal cells hold promise for skeletal tissue engineering. However, various studies have observed that adipose-derived stromal cells differ significantly in their biology depending on species of derivation. In the following study, the authors sought to determine the species-specific response of adipose-derived stromal cells to recombinant TGF-beta1 (rTGF-beta1). Adipose-derived stromal cells were derived from mouse and human sources. Recombinant TGF-beta1 was added to culture medium (2.5 to 10 ng/ml); proliferation and osteogenic and adipogenic differentiation were assessed by standardized parameters, including cell counting, alkaline phosphatase, alizarin red, oil red O staining, and quantitative real-time polymerase chain reaction. Recombinant TGF-beta1 was found to significantly repress cellular proliferation in both mouse and human adipose-derived stromal cells (p < 0.01). Recombinant TGF-beta1 was found to significantly repress osteogenic differentiation in mouse adipose-derived stromal cells. In contrast, osteogenic differentiation of human adipose-derived stromal cells proceeded unimpeded in either the presence or the absence of rTGF-beta1. Interestingly, rTGF-beta1 induced expression of a number of osteogenic genes in human adipose-derived stromal cells, including BMP2 and BMP4. The authors' results further detail an important facet in which mouse and human adipose-derived stromal cells differ. Mouse adipose-derived stromal cell osteogenesis is completely inhibited by rTGF-beta1, whereas human adipose-derived stromal cell osteogenesis progresses in the presence of rTGF-beta1. These data highlight the importance of species of derivation in basic adipose-derived stromal cell biology. Future studies will examine in more detail the species-specific differences among adipose-derived stromal cell populations.
    Plastic and Reconstructive Surgery 08/2010; 126(2):412-25. DOI:10.1097/PRS.0b013e3181df64dc · 3.33 Impact Factor